<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-7B08DM</udiDi>
    <basicUdiDi>B-7B08DM</basicUdiDi>
    <tradeName>Thyroid-Peroxidase Antibody assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7B08V1-B-EU, 7B08U1-B-EU, 7B08P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.460Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7B11DA</udiDi>
    <basicUdiDi>B-7B11DA</basicUdiDi>
    <tradeName>Thyroid Globulin assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7B11V1-B-EU, 7B11U1-B-EU, 7B11P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.441Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7B12DC</udiDi>
    <basicUdiDi>B-7B12DC</basicUdiDi>
    <tradeName>Thyrotropin Receptor Antibody assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7B12V1-B-EU, 7B12U1-B-EU, 7B12P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.424Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C01DC</udiDi>
    <basicUdiDi>B-7C01DC</basicUdiDi>
    <tradeName>Alpha-Fetoprotein assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C01V1-B-EU, 7C01U1-B-EU, 7C01P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.413Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C02DE</udiDi>
    <basicUdiDi>B-7C02DE</basicUdiDi>
    <tradeName>Cancer Embryo Antigen assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C02V1-B-EU, 7C02U1-B-EU, 7C02P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.400Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C03DG</udiDi>
    <basicUdiDi>B-7C03DG</basicUdiDi>
    <tradeName>Cancer Antigen 125 assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C03V1-B-EU, 7C03U1-B-EU, 7C03P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.384Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C04DJ</udiDi>
    <basicUdiDi>B-7C04DJ</basicUdiDi>
    <tradeName>Carbohydrate Antigen 19-9 assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C04V1-B-EU, 7C04U1-B-EU, 7C04P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.367Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C07DQ</udiDi>
    <basicUdiDi>B-7C07DQ</basicUdiDi>
    <tradeName>Ferritin assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C07V1-B-EU, 7C07U1-B-EU, 7C07P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.343Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C09DU</udiDi>
    <basicUdiDi>B-7C09DU</basicUdiDi>
    <tradeName>Neuron-Specific Enolase assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C09V1-B-EU, 7C09U1-B-EU, 7C09P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.329Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C10DD</udiDi>
    <basicUdiDi>B-7C10DD</basicUdiDi>
    <tradeName>Cancer Antigen 15-3 assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C10V1-B-EU, 7C10U1-B-EU, 7C10P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.315Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C13DK</udiDi>
    <basicUdiDi>B-7C13DK</basicUdiDi>
    <tradeName>Cytokeratin 19 Fragment 21-1 assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C13V1-B-EU, 7C13U1-B-EU, 7C13P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.299Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C15DP</udiDi>
    <basicUdiDi>B-7C15DP</basicUdiDi>
    <tradeName>Carbohydrate Antigen 72-4 assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C15V1-B-EU, 7C15U1-B-EU, 7C15P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.282Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C16DR</udiDi>
    <basicUdiDi>B-7C16DR</basicUdiDi>
    <tradeName>Pepsinogen I assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C16V1-B-EU, 7C16U1-B-EU, 7C16P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.268Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C17DT</udiDi>
    <basicUdiDi>B-7C17DT</basicUdiDi>
    <tradeName>Pepsinogen II assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C17V1-B-EU, 7C17U1-B-EU, 7C17P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.250Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C18DV</udiDi>
    <basicUdiDi>B-7C18DV</basicUdiDi>
    <tradeName>Gastrin-17 assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C18V1-B-EU, 7C18U1-B-EU, 7C18P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.231Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C20DG</udiDi>
    <basicUdiDi>B-7C20DG</basicUdiDi>
    <tradeName>Carbohydrate Antigen 242 assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C20V1-B-EU, 7C20U1-B-EU, 7C20P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.217Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C21DJ</udiDi>
    <basicUdiDi>B-7C21DJ</basicUdiDi>
    <tradeName>Squamous Cell Carcinoma assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C21V1-B-EU, 7C21U1-B-EU, 7C21P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:37:30.199Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7C22DL</udiDi>
    <basicUdiDi>B-7C22DL</basicUdiDi>
    <tradeName>Progastrin-Releasing Peptide assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7C22V1-B-EU, 7C22U1-B-EU, 7C22P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T21:51:49.917Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7D01DH</udiDi>
    <basicUdiDi>B-7D01DH</basicUdiDi>
    <tradeName>Follicle-Stimulating Hormone assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7D01V1-B-EU, 7D01U1-B-EU, 7D01P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T21:51:49.895Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-7D02DK</udiDi>
    <basicUdiDi>B-7D02DK</basicUdiDi>
    <tradeName>Luteinizing Hormone assay (CLIA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Xiamen Boson Biotech Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000001096</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7D02V1-B-EU, 7D02U1-B-EU, 7D02P1-B-EU</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T21:51:49.876Z</lastUpdated>
  </row>
</eudamedExport>